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used Raman microspectroscopy to characterize live A549 cells from a unique molecular biochemical perspective to shed light on
their suitability as a model for primary human pulmonary alveolar type II (ATII) cells. We also investigated a recently developed
transduced type I (TT1) cell line as a model for alveolar type I (ATI) cells. Single-cell Raman spectra provide unique biomolecular
ﬁngerprints that can be used to characterize cellular phenotypes. A multivariate statistical analysis of Raman spectra indicated
that the spectra of A549 and TT1 cells are characterized by signiﬁcantly lower phospholipid content compared to ATII and ATI
spectra because their cytoplasm contains fewer surfactant lamellar bodies. Furthermore, we found that A549 spectra are statis-
tically more similar to ATI spectra than to ATII spectra. The spectral variation permitted phenotypic classiﬁcation of cells based on
Raman spectral signatures with >99% accuracy. These results suggest that A549 cells are not a good model for ATII cells, but
TT1 cells do provide a reasonable model for ATI cells. The ﬁndings have far-reaching implications for the assessment of cell lines
as suitable primary cellular models in live cultures.INTRODUCTIONResearch into various diseases, such as cancer, often relies
on identifying drugs that influence cell growth and metabo-
lism, or induce cell death (1). Stem-cell-based therapies in
the context of regenerative medicine (2) and tissue engi-
neering (3) rely on understanding how cells differentiate and
interact with other cells, tissues, and materials. Primary stem,
progenitor, and lineage-specific cells are the gold standards
for studying cell growth and behavior in vitro. However,
the use of primary cells can be hampered by an unreliable
supply, the difficulty of performing isolation and culture
procedures in vitro, and loss of phenotype with increasing
time in culture. For example, primary pulmonary alveolar
type II (ATII) epithelial cells lose their distinctive phenotype
over a period of 1–2 weeks when cultured in vitro, as they
undergo spontaneous differentiation resulting in expression
of features characteristic of alveolar type I (ATI) cells (4).
To overcome these limitations, cell lines are often used as
models for primary cells. These cells are typically derived
from cancerous tissue or by immortalization of primary cells
through retroviral transfection or transduction (5). Cell lines
are generally easier to culture than primary cells, have a high
proliferation rate and long lifespan, and maintain their
phenotype in culture. However, the main disadvantage of
cell lines is that the phenotype they express may not be
consistent with the true phenotype of their primary counter-
parts (6).
The human A549 adenocarcinoma cell line has been used
in lung cell biology as a model for ATII cells. These highly
specialized cells produce surfactant, a multifunctional lubri-Submitted August 6, 2009, and accepted for publication December 9, 2009.
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lapse during ventilation. The A549 cell line was derived
from a type II pneumocyte lung tumor by Giard et al. in
1972 (7), and expresses some characteristic features of ATII
cells, including synthesis of phospholipids, cytoplasmic
lamellar bodies (Lbs), and apical microvilli (8). Since then,
A549 cells have been used for in vitro studies of surfactant
production and regulation of surfactant systems (9). How-
ever, the architecture and barrier properties of A549 cells
are quite distinct from those of ATII cells (10), and, unlike
primary ATII cells, cultured A549 cells do not undergo
a transition to express an ATI-like phenotype. These differ-
ences, along with inconsistencies regarding A549 expression
of ATII-specific markers, have led researchers to question
the suitability of this cell line as an appropriate model for
primary ATII cells (11).
In a recent study, we used Raman microspectroscopy to
noninvasively characterize the in vitro differentiation of
primary ATII cells to ATI cells (12). Raman microspectro-
scopy is a laser-based analytical technique that enables
chemical characterization of molecules within a sample. It
is a nondestructive optical technique based on the inelastic
scattering of photons by molecular bond vibrations (13).
A small fraction of photons are scattered by interaction
with chemical bonds, resulting in a shift toward lower
frequencies. The energy differences between incident and
scattered photons correspond to specific vibrational energies
of chemical bonds of the scattering molecules. The Raman
spectrum of a cell represents an intrinsic biochemical finger-
print that contains molecular-level information about all
cellular biopolymers. Raman spectroscopy has advantages
over conventional cytochemical techniques because it allows
rapid, noninvasive sensing, and the weak Raman scatteringdoi: 10.1016/j.bpj.2009.12.4289
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the absence of fixatives or labels (14). And whereas most
biological assays probe for only a single marker, Raman
spectroscopy simultaneously probes all molecular moieties.
Furthermore, since Raman spectra are sensitive to changes
in molecular composition, they can be used as cell-specific
biochemical signatures to discriminate between different
cellular phenotypes. Noninvasive spectral analysis has
been used to identify cancer cells to aid in disease detection
(15), as a biosensor to monitor cellular response to pharma-
ceuticals (16) and in vitro osteogenesis (17), and as a
cytology tool to investigate cellular organelles (18), bio-
chemistry (19), apoptosis (20), and differentiation (21).
In this study, we used Raman microspectroscopy for live
cell culture analysis to compare the A549 phenotype with
that of primary human ATII cells. We also investigated an
immortal alveolar type I-like cell line (transduced type I
(TT1)) that was recently developed and characterized by
Kemp et al. (22) as a model for ATI cells. A549 and TT1
cells were tested for expression of ATII-specific (alkaline
phosphatase (ALP), pro-surfactant protein C (pro-SPC)),
and ATI-specific (caveolin-1) markers to correlate Raman
spectral profiles with cellular phenotype. We used several
well-established chemometric techniques, including prin-
cipal components analysis (PCA), linear discriminant anal-
ysis (LDA), and spectral modeling to identify spectral
markers that describe the biochemical differences between
primary pulmonary alveolar epithelial cells and their model
cell lines.MATERIALS AND METHODS
Cell culture, cytochemical staining,
and immunoblotting
Cells were cultured in media appropriate to each cell type, as surmised from
previous studies within our laboratory and relevant studies within the liter-
ature. Primary human ATII cells were isolated and cultured as described
previously (23). For staining and immunoblotting, purified ATII cells
(0.75  106 cells/mL) were cultured on collagen type-I (1% (w/v) Vitro-
gen-100 (Imperial Laboratories, Andover, UK) in sterile deionized water,
dried overnight) coated plates in defined cell culture medium 1 (DCCM-1;
React Scientific, Ayr, UK) containing 10% (v/v) newborn calf serum,
100 U/mL penicillin, 100 mg/mL streptomycin, and 2 mM glutamine. The
dilute collagen coating was used to promote cellular attachment and is
unlikely to influence the analytical results. For characterization by Raman
microspectroscopy, ATII cells (0.20  106 cells/mL) were cultured on
collagen type-I coated MgF2 coverslips (Global Optics, Bournemouth,
UK) in DCCM-1, with supplements as above. MgF2 is a weak Raman scat-
terer and is commonly used as a cell culture substrate for Raman spectros-
copy (24). A lower seeding density was used for MgF2 to facilitate collection
of spectra from individual cells.
Human A549 lung carcinoma cells (American Type Culture Collection,
Manassas, VA) were cultured in Dulbecco’s modified Eagle’s medium
(DMEM) supplemented with 10% (v/v) fetal bovine serum (Invitrogen,
Paisley, UK) and 1% (v/v) antibiotic/antimycotic (A/A; Invitrogen).
Immortal TT1 cells were obtained by retroviral transduction of ATII cells
as described by Kemp et al. (22), and cultured in DCCM-1 supplemented
with 0.5 mg/mL G418 (Sigma, Dorset, UK). Cell lines were grown toBiophysical Journal 98(8) 1703–171170% confluence before seeding (1.0  104 cells/mL) onto sterilized MgF2
coverslips (not collagen-coated).
Staining for Lbs, ALP, and pro-SPC, and immunoblotting of caveolin-1
were performed as described previously (25,26). Additional details are
provided in the Supporting Material.
Raman microspectroscopy
Raman spectra were measured with a Renishaw InVia spectrometer
(Renishaw, Wotton-under-Edge, Gloucestershire, UK) connected to a Leica
microscope (Leica, Wetzlar, Germany), as described previously (12).
A high-power 785 nm diode line focus laser (~50 mW at the sample) was
focused on cells by a 63 (NA ¼ 0.9) long working distance (2 mm) water
immersion objective (Leica). Under these conditions, the laser illuminates an
elliptical region at the focal plane (10 mm 20 mm lateral spatial resolution).
The use of near-infrared radiation permits the use of high laser powers for
nondestructive cellular analysis (24,27). Spectra of living cells were
measured in DMEM with 1% (v/v) A/A at 37C. Cells were serum-starved
overnight for synchronization in the G0/G1 phase of the cell cycle to
minimize cell-cycle-related spectral variance (28). Individual spectra were
recorded for 40 s at a resolution of ~1–2 cm1. Raman backscattered radia-
tion was directed through a holographic notch filter and 50 mm slit into the
spectrometer (1200 lines/mm grating) before detection with a deep-depletion
charge-coupled device detector.
Undifferentiated ATII cells were analyzed 3–4 days postseeding, and
differentiated ATI cells were analyzed on days 10–11 and 17–18 postseed-
ing. Two-day time points were used to allow analysis of sufficient cell
numbers. Raman spectra of A549 and TT1 cells were collected between
72 and 96 h postseeding. Cells were characterized by computing the average
spectra from multiple measurements per cell, and all efforts were taken to
minimize the potential for overlap artifacts during signal collection.
Data analysis
All Raman data were analyzed with software developed in-house for MatLab
(The Mathworks, Natick, MA). Spectra were intensity-corrected for instru-
ment response (24), normalized with extended multiplicative signal correc-
tion (EMSC) (29), and smoothed using a Savitsky-Golay filter (five points,
second-order polynomial), with the wavenumber axis aligned to the sharp
phenylalanine peak at 1003 cm1 and truncated to 600–1800 cm1.
EMSC also correct spectra for variable background signal.
A least-squares fitting procedure was used to estimate the signal contri-
bution of biochemical components to cellular Raman spectra, as described
previously (12). Each mean cell spectrum was modeled by a linear combi-
nation of basis spectra representative of cellular biochemical components
(Fig. S1), including nucleic acids (DNA and RNA), proteins (actin, human
serum albumin, chymotrypsin, and collagen), carbohydrates (glycogen),
and lipids (phosphatidyl choline (PCh) and cholesterol). A fifth-order poly-
nomial was used to model the background signal, which can be attributed
to scattering from DMEM culture medium and MgF2 substrate, and fluo-
rescence from aromatic compounds (16). To assess the quality of the fit,
we compared the model spectra with the empirical data by examining
residuals and computing correlation coefficients. The correlation coefficient
provides a statistical measure of the similarity between spectra (30), and
was used here as a goodness-of-fit parameter (R ¼ 1 for identical spectral
profiles).
PCA is a data compression algorithm that can be used to express high-
dimensional spectra in terms of a small number of principal components
(PCs) (31). PCs are orthogonal eigenvectors of the data covariance matrix,
with the greatest variance captured by PC1, the second-greatest variance
captured by PC2, etc. As such, the PCs form a set of basis spectra, and
PC score values are weighting coefficients that describe the contribution
of PCs to the original data. When applied to Raman spectra, PCs contain
spectral features corresponding to the main molecular species responsible
for the statistical variation between spectra. We carried out separate two-
group comparisons: one between ATII and A549 cells, and one between
Raman Spectral Phenotyping of Lung Cells 1705ATI and TT1 cells. In each case, only spectra of cells within the two groups
being compared were included in the PCA. In addition, we also performed
a four-group PCA that incorporated spectra of all four cell types.
LDA is a supervised classification algorithm for discrimination of sample
groups. The algorithm computes linear discriminant functions that maximize
the ratio of between-class variance to within-class variance according to
Fisher’s criterion (32). Since LDA requires fewer variables than observa-
tions, PCA was used to compress the spectra and the PC scores were used
as input for LDA. We assessed the accuracy of classification using the
leave-one-out cross-validation method, whereby the class of a spectrum is
predicted by means of an LDA model built from the full data set, excluding
the spectrum in question. This method is repeated, with each spectrum left
out in turn, so that the class of each spectrum is predicted once.RESULTS
Cytochemical characterization of lung cell
phenotypes
Differentiation of primary ATII cells proceeded as described
previously (12). Undifferentiated ATII cells were cuboidal,
stained positive for ATII-specific cell markers Lbs
(Fig. 1 A), ALP, and pro-SPC, and only weakly expressed
caveolin-1, an ATI-specific marker (Fig. S2). With
increasing time in culture, the cells adopted a flattened
morphology with a raised perinuclear region and thin cyto-
plasmic attenuations. The staining pattern at later time points
shifted to a strong expression of caveolin-1 and a weak
expression of ALP, pro-SPC, and Lbs, confirming the spon-
taneous differentiation of ATII cells to an ATI cell phenotype
in vitro.For the cell lines, no differences in growth, morphology,
or expression of phenotypic markers were observed between
MgF2 and tissue culture substrates. The A549 cells typically
were small and cuboidal, and stained positive for numerous
Lbs (Fig. 1 C), although Lb staining was less intense and
uniform than observed in ATII cells (Fig. 1 A). TT1 cell
morphology was similar to that of ATI cells, but TT1 cells
were less squamous and thin cytoplasmic attenuations were
less prevalent. Lb staining was weakest in TT1 cells
(Fig. 1 D), and neither A549 nor TT1 cells expressed ALP
or pro-SPC (Fig. S2, A and B). Immunoblotting revealed
positive expression of caveolin-1 in cultures of TT1 cells,
although at lower levels than observed in ATI cell cultures.
Caveolin-1 expression by A549 cells was extremely weak
or negative (Fig. S2 C).Spectral variability within cells
We measured Raman spectra at different positions in each
cell to study spectral variation with respect to subcellular
location. Similar patterns of spectral heterogeneity were
observed in all cell types, and in general, cytoplasm spectra
exhibited stronger lipid vibrations than spectra collected
from cell nuclei, which were dominated by protein and
nucleic acid spectral features. The strong phospholipid
vibrations observed in the cytoplasm spectra (Fig. 2) are
due to the presence of surfactant-containing Lbs in all cell
types.FIGURE 1 Morphology of cells cultured on MgF2
coverslips. Light-microscope images of (A) ATII, (B)
ATI, (C) A549, and (D) TT1 cells stained for Lbs with
osmium tetroxide and tannic acid. Dark osmiophilic gran-
ules indicate cytoplasmic Lbs. Scale bar ¼ 20 mm.
Biophysical Journal 98(8) 1703–1711
FIGURE 2 Raman spectrum of PCh (line a); typical
Raman spectra collected from the cytoplasm of ATII cells
(line b), A549 cells (line c), ATI cells (line d) and TT1 cells
(line e). Spectra have been corrected for instrument
response, EMSC normalized, baseline-corrected, wave-
number alignment, and vector normalized. Light micro-
scope pictures indicate the region probed by each scan.
Spectra are offset for clarity. Scale bar ¼ 10 mm. Correla-
tion coefficients between the PCh spectrum and ATII,
A549, ATI, and TT1 cytoplasm spectra shown are
R ¼ 0.970, 0.889, 0.859, and 0.817, respectively.
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living cells
ATII cells had typical dimensions of ~20 mm  30 mm, and
we found that three spectra were adequate to probe single
ATII cells. Spectra of the perinuclear region of ATI cells
demonstrated high intensity and a good signal/noise ratio,
whereas those of the thin cytoplasmic attenuations were
weak and noisy, and did not display significant features
above the signal of the culture medium. Therefore, our anal-
ysis of ATI cells was based on perinuclear cellular regions
only, which were similar in size to ATII cells (12). Thus,
the mean spectra representing the biomolecular fingerprints
of individual ATII and ATI cells were based on three spectral
measurements per cell. A549 and TT1 cells were typically
larger than ATII cells and their size was more variable; there-
fore, mean A549 and TT1 cell spectra were computed from
three to five measurements per cell, depending on cell size
and shape.
The average processed Raman spectra of all ATII and
A549 cells are shown in Fig. 3 A, and those of ATI and
TT1 cells are shown in Fig. 3 B. The solid black lines denote
average spectra, which represent the mean of 183, 250, 375,
and 222 spectra collected from 61 ATII, 57 A549, 125 ATI,
and 56 TT1 cells, respectively. The small standard deviations
(SDs; gray lines) within each group indicate that Raman
spectral characterization of lung cell phenotypes is highly
reproducible. The spectra consist of peaks corresponding
to molecular vibrations of all cellular biopolymers. Specific
assignments of individual peaks, compiled from previous
studies (12,18,24), are presented in Table S1. Scatterplots
of the intensity values of the main peaks that differ betweenBiophysical Journal 98(8) 1703–1711spectra of primary cells and cell lines are shown in Fig. S3.
All peaks indicated in Fig. 3 have significantly different
(p < 0.05) mean intensities, determined using the Mann-
Whitney test. The lack of sharp, derivative-like peak features
in the difference spectra (ATII-A549 and ATI-TT1) of Fig. 3
indicate that no shifting of major Raman bands was observed
in the spectra of the different cell types reported here.
Spectral modeling
We fit the mean spectra of individual lung cells with a set of
basis spectra modeling cellular biochemical components
using a nonnegative least-squares fitting routine. Examples
of the fitting results are displayed in Fig. 4, where the
mean overall spectra of ATII, A549, ATI, and TT1 cells
are plotted along with the model-predicted spectra and
residuals. Low-intensity residual spectra and high correlation
coefficients obtained for all ATII (Rmean ¼ 0.9955 0.002),
A549 (Rmean ¼ 0.995 5 0.003), ATI (Rmean ¼ 0.994 5
0.002), and TT1 cells (Rmean ¼ 0.993 5 0.002)
indicate that the least-squares model provides a good fit to
the data.
To determine the signal contributions of the biochemical
components to cellular spectra, we normalized the model
fit coefficients for each individual cell to unity sum, and
calculated the mean 5 SDs for each cell type (Table 1).
The results are grouped together in terms of component clas-
sification (nucleic acids, proteins, carbohydrates, and lipids)
because, despite the presence of some distinct peaks within
component spectra, the nonorthogonal nature of similar basis
spectra prevents spectral resolution of individual compo-
nents (33). Differences in normalized fit coefficients between
FIGURE 3 Average Raman spectra of (A) ATII and A549 cells, and (B)
ATI and TT1 cells. Solid black lines denote average spectra, and gray lines
delineate 1 SD. Spectra are offset for clarity. Difference spectra (ATII-A549
and ATI-TT1) are also included (magnified by a factor of 2.5).
Raman Spectral Phenotyping of Lung Cells 1707primary cells and cell lines were tested for statistical signif-
icance using the Mann-Whitney test.FIGURE 4 Spectral modeling of (A) ATII and A549 cells, and (B) ATI
and TT1 cells. Mean spectra are shown in black, model fits in gray, and
residual spectra in black, offset for clarity. Correlation coefficients between
the mean and model spectra shown are R ¼ 0.996, 0.997, 0.996, and 0.994,
respectively.PCA
PCAwas performed on themean Raman spectra of individual
lung cells. A PC-score plot is a bivariate scatterplot in which
data are depicted in terms of spectral coordinates. These plots
facilitate comparison of different cell types (clustering or
grouping within score plots indicates systematic differences
between groups of spectra). Direct two-group comparisons
between ATII/A549 and ATI/TT1 cells are presented in
Fig. 5, A and B, respectively. We also performed a PCA on
the entire data set to compare all four cell types (Fig. S4).
The size and position of cell clusters in the four-group PCA
are indicated in Fig. 5 C. Details of the percent variance
described by each plot are provided in the figure captions.LDA
PC-score plots are two-dimensional projections of high-
dimensional spectral data, and discrimination is based on a
limited portion of the total variance. LDA is an extension
of PCA that incorporates much more spectral variance as
well as class membership of data to produce maximal group
separation. To determine whether ATII and A549 cells couldBiophysical Journal 98(8) 1703–1711
TABLE 1 Relative percent signal contribution of model basis
components to cellular Raman spectra
Cell type Nucleic acid (%) Protein (%) CHO* (%) Lipid (%)
ATII (n ¼ 61) 11.85 2.0 51.85 7.7 8.55 1.6 27.95 8.8
A549 (n ¼ 57) 11.65 3.5 61.15 5.7y 5.55 2.4y 21.75 9.0y
ATI (n ¼ 125) 9.7 5 2.9 62.15 5.2 9.35 1.2 18.95 6.5
TT1 (n ¼ 56) 15.05 2.1z 61.05 3.9z 8.45 1.5z 15.75 5.9z
*CHO ¼ carbohydrate.
y and z denote statistically significant differences between ATII/A549
and ATI/TT1 cells, respectively (computed using the Mann-Whitney test,
p < 0.05).
1708 Swain et al.be distinguished solely by their Raman spectra, we used the
scores on the first 25 PCs (accounting for 96.2% of variance)
generated in the direct ATII-A549 comparison to develop
an LDA classification model. A separate 25-PC model
(accounting for 94.3% of variance) was developed to distin-
guish between spectra of ATI and TT1 cells. PC-LDA
models were obtained by starting with two PCs and incorpo-
rating additional PCs until data classification was optimal.
Cross-validation of the ATII-A549 LDA model revealed
100% sensitivity and specificity for both cell types, with
all 61 ATII and 57 A549 cells classified correctly. In the
ATI-TT1 LDA model cross-validation, all 56 TT1 cells
and 124/125 ATI cells were classified correctly, yielding
99% sensitivity, 100% specificity for ATI cells, and 100%
sensitivity, 98% specificity for TT1 cells.FIGURE 5 PC1-PC2 score plots. Direct PCA of (A) ATII versus A549
cells, and (B) ATI versus TT1 cells. These plots incorporate 73.7%
(60.3% on PC1, 13.4% on PC2) of the variance between ATII and A549
cell spectra, and 59.5% (45.8% on PC1, 13.7% on PC2) of the variance
between ATI and TT1 cell spectra. (C) Score plot from four-group PCA,
as in Fig. S4, with shaded regions showing the position of all four data
clusters (data points removed for clarity).DISCUSSION
The appropriate use of cell lines as models for primary cells
is important in cancer research, stem cell research, and tissue
engineering. As such, the degree to which the phenotype
expressed by cell lines represents that of the primary system
is of central relevance. The suitability of the A549 cell line as
a model for ATII cells was initially questioned by Mason and
Williams (11) in 1982, when they discovered that the surfac-
tant produced by A549 cell cultures differed significantly
from that of primary (murine) ATII cells. Since then, discrep-
ancies regarding A549 cell expression of ATII-specific
ultrastructural and cytochemical markers have led
researchers to further question the stability and robustness
of the A549 cell line. In contrast, a recently developed
type I cell line (TT1) has been shown to express ATI-specific
markers (22), and displays potential as a model for studying
the biochemical and transport properties of primary ATI
cells.
In this work, we aimed to scrutinize the appropriateness of
A549 and TT1 cell lines as models for primary ATII and ATI
cells, respectively. We used Raman microspectroscopy as a
novel phenotypic characterization method to assess these
models from a unique perspective, and by validating our
results with gold-standard cytochemical techniques, we
were able to obtain a more comprehensive view by which
to judge the merits of the cell line models.Biophysical Journal 98(8) 1703–1711
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phenotypes
The A549 cell line has been extensively characterized (8,34)
and used as a model for primary ATII cells. Although it was
shown to produce phospholipids and stain positive for Lbs
(34), several discrepancies with respect to A549 expression
of ATII-specific markers are reported in the literature. Fuchs
et al. (4) characterized A549 cells as expressing high levels
of SPC and low levels of caveolin-1, indicating an ATII
phenotype. This was supported by Campbell et al. (35),
who reported that A549 cells lack caveolae and only weakly
express caveolin-1 (both of which are ATI cell markers).
However, Witherden et al. (25) did not detect expression
of SPC or surfactant protein A mRNA by A549 cells. The
A549 cultures examined here were negative for ALP (in
agreement with McCormick et al. (36)) and pro-SPC, and
weakly expressed both isoforms of caveolin-1 (Fig. S2 C),
indicating significant differences between the phenotypes
of A549 and ATII cells. With respect to other markers, Car-
olan and Casale (37) found that A549 cells demonstrate
significantly lower transepithelial electrical resistance than
primary ATII cells, Nakano et al. (38) reported strong
expression of the ATI-specific marker receptor for advanced
glycation end products, and Pechkovsky et al. (39) found
significant differences in expression of nitric oxide synthase
mRNA between ATII and A549 cells. It has been suggested
that the conflicting results regarding A549 cells reflect incon-
sistencies among batches of A549 cells, possibly depending
on culture conditions and passage number (25). The A549
cells examined here clearly express some phenotypic
features of both primary ATII cells (positive Lb stain,
weak caveolin-1 expression) and ATI cells (negative staining
for ALP and pro-SPC).
TT1 cell morphology was consistent with that of ATI
cells, with weak staining for Lbs. Several vacuole-like struc-
tures were observed and could be reminiscent of residual or
incomplete Lbs (4). In addition, TT1 cells did not stain posi-
tive for ALP or pro-SPC, but did express caveolin-1, albeit
at a lower level than cultures of in vitro-derived ATI cells
(Fig. S2 C). These results agree with the recent characteriza-
tion of TT1 cells by Kemp et al. (22) and indicate that, based
on the markers probed here, TT1 cells express an ATI-like
phenotype. This was expected because the immortalized
TT1 cell line was derived from cultures of primary ATII cells
that had spontaneously differentiated toward an ATI pheno-
type (22), as occurs in vivo.
Raman spectral characterization
of lung cell phenotypes
Biomolecular characterization of lung cells with Raman mi-
crospectroscopy revealed that both primary cells and cell
lines exhibit variation between lipid-rich cytoplasm spectra
and protein/nucleic acid-dominated nucleus spectra. Correla-
tion coefficients between the spectrum of PCh and ATIIcytoplasm spectra (Fig. 2) were typically much higher than
those computed for ATI, A549, and TT1 cytoplasm spectra,
confirming a significantly higher contribution of phospho-
lipid molecular vibrations to ATII cytoplasm spectra. This
is due to a higher concentration of phospholipid-rich Lbs
in the cytoplasm of ATII cells (Fig. 1).
An average Raman spectrum was computed for each cell
to compare cellular biomolecular signatures within and
between groups of ATII, A549, ATI, and TT1 cells. Raman
analysis produced highly reproducible and informative
spectra. The small SDs about the mean spectra (Fig. 3, A
and B, gray lines) suggest consistent phenotypic character-
ization with Raman microspectroscopy. This was expected
for immortalized and cancer cell lines, but surprisingly was
also observed within cultures of primary ATII and ATI cells,
reflecting the high ATII cell purity (~95%) afforded by our
isolation protocol (23).
The main differences between the spectra of ATII and
A549 cells are highlighted by the difference spectrum in
Fig. 3 A and the scatterplot in Fig. S3 A. Mean ATII cell
spectra had significantly stronger peaks corresponding
to phospholipid vibrations (717, 872, 1061, 1082, and
1301 cm1), whereas peaks associated with protein vibra-
tions (685 cm1, 985 cm1, extended amide III band
~1265 cm1) were more intense in the spectra of A549 cells.
Also, the amide I band (~1657 cm1) was broader in the
spectra of A549 cells compared to ATII cells, indicating
lower unsaturated phospholipid and higher protein content.
These univariate peak observations were supported by multi-
variate spectral modeling (Table 1), which revealed on
average a 6% higher phospholipid signal contribution to
ATII spectra than to A549 spectra. In fact, the pattern of
biochemical signal contribution to spectra of A549 cells
had more similarity to ATI cells than to ATII cells. The
protein signal contribution to mean A549 spectra was ~10%
higher than for ATII spectra. The reason for the significant
difference between carbohydrate signal content in the spectra
of ATII and A549 cells is unclear at present, but may be an
artifact of modeling complex cellular spectra with a limited
number of nonorthogonal basis spectra. Furthermore, since
the data are expressed as relative rather than absolute
amounts, the reduced carbohydrate content in A549 spectra
may simply reflect an increase in one or more of the other
cellular constituents.
The significant differences between ATI and TT1 spectra
indicated in Fig. 3 B and Fig. S3 B include variation in the
molecular vibrations of phospholipids (717 cm1), proteins
(855, 872, and 937 cm1, upper region of amide I band
~1680 cm1), nucleic acids (785 and 1375 cm1), as well
as vibrations common to all molecular moieties (e.g., CH
deformation vibrations at 1449 cm1). These findings were
supported by spectral modeling, which revealed significant
differences in the signal contributions of all biomolecular
components to spectra of ATI and TT1 cells. In particular,
the signal contribution of nucleic acids to TT1 spectra wasBiophysical Journal 98(8) 1703–1711
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a higher proliferation rate in the transduced cell line. In addi-
tion, the lipid signal contribution to TT1 spectra was signif-
icantly lower (by ~3%) than that to primary ATI spectra.Spectral discrimination via PCA and LDA
The PCs contain spectral features that describe the biomolec-
ular species responsible for discrimination of cell popula-
tions. In the data sets examined here, the biomolecular
species implicated by the PC loading vectors were consistent
with those identified by multivariate spectral modeling. The
PC1-PC2 score plots in Fig. 5 depict clusters of cell popula-
tions, grouped on the basis of spectral similarity. The cluster
patterns indicate that primary ATII and ATI cells cannot
completely be distinguished from model A549 and TT1
cell lines with only two PCs. In particular, the observed vari-
ability among A549 cells was larger than initially expected,
but is likely to reflect inconsistent phenotypic expression of
A549 cells as discussed above. However, despite overlap in
the PC score plots, the more sensitive LDA results demon-
strate that one can discriminate between ATII/A549 cells
and ATI/TT1 cells by incorporating additional spectral infor-
mation (i.e., by using 25 PCs). The additional information
enabled 100% spectral discrimination between ATII and
A549 cells, and >99% classification accuracy of ATI and
TT1 cells. The latter result, coupled with the distinct cluster
centroids for ATI and TT1 cells shown in Fig. 5 B, suggests
that, although they exhibit similar staining and immunoblot-
ting patterns (Fig. 1 and Fig. S2), immortalized TT1 cells are
spectrochemically distinct from their primary counterpart.
This demonstrates the high sensitivity of Raman microspec-
troscopy in comparison with traditional cytochemical tech-
niques for detecting cellular biochemical alterations induced
by transduction. And, in contrast to the conflicting results of
cytochemical experiments comparing A549 and ATII cells,
our Raman-based analysis clearly identifies distinct bio-
chemical differences between these cell types.
Interestingly, clustering in the combined PC1-PC2 score
plot (Fig. S4) indicated that A549 spectra occupy a region
similar to those of ATI and TT1 cells (Fig. 5 C). Thus,
with respect to the common basis vectors PC1 and PC2,
A549 spectra are more similar to spectra of ATI cells than
those of ATII cells. These findings, supported by LDA and
biochemical signal profiles determined by spectral modeling,
suggest that A549 cells are not a good model for primary
ATII cells, for if they were, we would expect A549 and
ATII clusters to occupy a similar region within the PC1-
PC2 score plot. In light of these findings and the inconsis-
tency of the A549 phenotype, it is important to recognize
the limitations of the A549 cell line as a substitute for ATII
cells. The A549 cell line may be appropriate for use in cancer
studies of adenocarcinoma, as a monolayer culture to mimic
ATI cells in studies of solute transport (40), and as a model
for dysfunctional ATII cells, as suggested by Balis et al. (41).Biophysical Journal 98(8) 1703–1711In contrast, our analysis suggests that the TT1 cell line
provides a suitable model for ATI cells, exhibiting positive
expression of ATI-specific markers and negative expression
of ATII-specific markers. However, a multivariate statistical
comparison of ATI and TT1 spectra did reveal key biochem-
ical differences between these spectrochemically distinct cell
types. This finding underscores the point that no model is
perfect, and one should always bear the limitations of a
particular model in mind when using it to represent a primary
system.CONCLUSIONS
Previous phenotypic characterizations of A549 cells by tradi-
tional cytochemical techniques have led to an inconsistent
view as to whether they provide a suitable model for primary
ATII cells. The results of Raman spectral phenotyping of
ATII and A549 cells presented here cast further doubt on
the use of A549 cells to represent ATII cells. The spectra
of A549 cells were statistically more similar to those of
differentiated ATI cells than to those of undifferentiated
ATII cells, and we were able to achieve 100% spectral
discrimination between ATII and A549 cells. In contrast to
the shortcomings of the A549 cell line model of primary ATII
cells, the recently developed TT1 cell line exhibits positive
expression of ATI-specific markers and negative expression
of ATII-specific markers, and thus provides a suitable model
for ATI cells. A multivariate statistical comparison of ATI
and TT1 cell spectra did, however, reveal key biochemical
differences between these spectrochemically distinct cell
types. These results suggest that investigators should give
careful consideration to the limitations of cell lines when
using them to model primary cells in biological applications.SUPPORTING MATERIAL
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